Goff BA - Search Results

1

BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer.

Lui GYL, Shaw R, Schaub FX, Stork IN, Gurley KE, Bridgwater C, Diaz RL, Rosati R, Swan HA, Ince TA, Harding TC, Gadi VK, Goff BA, Kemp CJ, Swisher EM, Grandori C. Lui GYL, et al. Among authors: goff ba. EBioMedicine. 2020 Oct;60:102988. doi: 10.1016/j.ebiom.2020.102988. Epub 2020 Sep 11. EBioMedicine. 2020. PMID: 32927276 Free PMC article.

2

The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma.

Swisher EM, Gown AM, Skelly M, Ek M, Tamimi HK, Cain JM, Greer BE, Muntz HG, Goff BA. Swisher EM, et al. Among authors: goff ba. Gynecol Oncol. 1996 Jan;60(1):81-8. doi: 10.1006/gyno.1996.0015. Gynecol Oncol. 1996. PMID: 8557233

3

Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis.

Paley PJ, Swisher EM, Garcia RL, Agoff SN, Greer BE, Peters KL, Goff BA. Paley PJ, et al. Among authors: goff ba. Gynecol Oncol. 2001 Feb;80(2):176-80. doi: 10.1006/gyno.2000.6071. Gynecol Oncol. 2001. PMID: 11161856

4

Use of complementary and alternative medicine among women with gynecologic cancers.

Swisher EM, Cohn DE, Goff BA, Parham J, Herzog TJ, Rader JS, Mutch DG. Swisher EM, et al. Among authors: goff ba. Gynecol Oncol. 2002 Mar;84(3):363-7. doi: 10.1006/gyno.2001.6515. Gynecol Oncol. 2002. PMID: 11855870

5

Pathologic findings in prophylactic oophorectomy specimens in high-risk women.

Leeper K, Garcia R, Swisher E, Goff B, Greer B, Paley P. Leeper K, et al. Gynecol Oncol. 2002 Oct;87(1):52-6. doi: 10.1006/gyno.2002.6779. Gynecol Oncol. 2002. PMID: 12468342

6

The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer.

Everett E, Tamimi H, Greer B, Swisher E, Paley P, Mandel L, Goff B. Everett E, et al. Gynecol Oncol. 2003 Jul;90(1):150-7. doi: 10.1016/s0090-8258(03)00232-4. Gynecol Oncol. 2003. PMID: 12821356

7

Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer.

Swisher EM, Wollan M, Mahtani SM, Willner JB, Garcia R, Goff BA, King MC. Swisher EM, et al. Among authors: goff ba. Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):662-7. doi: 10.1016/j.ajog.2005.01.054. Am J Obstet Gynecol. 2005. PMID: 16150257

8

Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer.

Shah C, Johnson EB, Everett E, Tamimi H, Greer B, Swisher E, Goff B. Shah C, et al. Gynecol Oncol. 2005 Dec;99(3):564-70. doi: 10.1016/j.ygyno.2005.06.011. Epub 2005 Oct 24. Gynecol Oncol. 2005. PMID: 16246402

9

Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium.

Puget Sound Oncology Consortium; Swisher EM, Swensen RE, Greer B, Tamimi H, Goff BA, Garcia R, Koh WJ. Puget Sound Oncology Consortium, et al. Among authors: goff ba. Gynecol Oncol. 2006 Jun;101(3):429-35. doi: 10.1016/j.ygyno.2005.10.032. Epub 2005 Dec 9. Gynecol Oncol. 2006. PMID: 16337995 Clinical Trial.

10

The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer.

Lachance JA, Everett EN, Greer B, Mandel L, Swisher E, Tamimi H, Goff B. Lachance JA, et al. Gynecol Oncol. 2006 Jun;101(3):470-5. doi: 10.1016/j.ygyno.2005.11.009. Epub 2006 Jan 18. Gynecol Oncol. 2006. PMID: 16413048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page